Biotech

All Articles

F 2G brings up $100M for 2nd effort to get new antifungal to market

.After F2G's initial attempt to get a brand-new lesson of antifungal to market was thwarted due to t...

Moderna targets $1.1 B in R&ampD costs slices, falls 5 plans amid success tensions

.Moderna has pledged to reduce R&ampD spending by $1.1 billion through 2027. The choice to shrink th...

Sanofi's $80M bank on Pivot dystrophy medicine finishes in stage 3 fail

.Only 4 months after Sanofi bet $80 million in beforehand money on Key Therapies' losmapimod, the sy...

Oncternal share drains 60% among unemployments, trial terminations

.Cancer firm Oncternal Therapeutics is actually folding all its own scientific trials and also layin...

Roche is carrying out chances that its own injectable weight problems possibility can inevitably demonstrate 25% weight management in late-stage test

.Roche is keeping out hopes that its own injectable weight problems prospect might ultimately displa...

Novo Nordisk hails 'outstanding' fat burning result for dual-acting oral medication in early trial

.Novo Nordisk has actually elevated the top on a stage 1 test of its oral amylin as well as GLP-1 re...

AbbVie takes legal action against BeiGene over blood cancer drug proprietary knowledge

.Simply a couple of short weeks after gaining an FDA Fast lane tag for its investigational BTK degra...

Lilly provides one-two blow with second tranche of good data on every week the hormone insulin applicant

.Soon after a positive records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based compan...

BridgeBio cuts genetics therapy spending plan as scientific information let down

.BridgeBio Pharma is actually slashing its own gene treatment finances and pulling back coming from ...

GSK submits HSV injection wishes after stage 2 stop working, transferring race to Moderna, BioNTech

.GSK's try to build the very first vaccination for herpes simplex virus (HSV) has finished in failur...